ATE552500T1 - Lipophile, farbstoffbasierte fret-assays für die clostridientoxinaktivität - Google Patents
Lipophile, farbstoffbasierte fret-assays für die clostridientoxinaktivitätInfo
- Publication number
- ATE552500T1 ATE552500T1 AT10164461T AT10164461T ATE552500T1 AT E552500 T1 ATE552500 T1 AT E552500T1 AT 10164461 T AT10164461 T AT 10164461T AT 10164461 T AT10164461 T AT 10164461T AT E552500 T1 ATE552500 T1 AT E552500T1
- Authority
- AT
- Austria
- Prior art keywords
- clostridial toxin
- clostridial
- toxinactivity
- lipophilic
- dye
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/5014—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing toxicity
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
- G01N33/5058—Neurological cells
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/536—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase
- G01N33/542—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase with steric inhibition or signal modification, e.g. fluorescent quenching
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
- G01N33/56911—Bacteria
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/94—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving narcotics or drugs or pharmaceuticals, neurotransmitters or associated receptors
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Hematology (AREA)
- Chemical & Material Sciences (AREA)
- Urology & Nephrology (AREA)
- Cell Biology (AREA)
- Pathology (AREA)
- General Physics & Mathematics (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Analytical Chemistry (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Tropical Medicine & Parasitology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Toxicology (AREA)
- Virology (AREA)
- Neurology (AREA)
- Pharmacology & Pharmacy (AREA)
- Neurosurgery (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Solid-Sorbent Or Filter-Aiding Compositions (AREA)
- Glass Compositions (AREA)
- Valve-Gear Or Valve Arrangements (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US66894205P | 2005-04-05 | 2005-04-05 |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE552500T1 true ATE552500T1 (de) | 2012-04-15 |
Family
ID=36975328
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT10164461T ATE552500T1 (de) | 2005-04-05 | 2006-04-04 | Lipophile, farbstoffbasierte fret-assays für die clostridientoxinaktivität |
AT06749210T ATE470857T1 (de) | 2005-04-05 | 2006-04-04 | Lipophile, farbstoffbasierte fret-assays für die clostridientoxinaktivität |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT06749210T ATE470857T1 (de) | 2005-04-05 | 2006-04-04 | Lipophile, farbstoffbasierte fret-assays für die clostridientoxinaktivität |
Country Status (10)
Country | Link |
---|---|
US (2) | US8124357B2 (de) |
EP (2) | EP2293064B1 (de) |
AT (2) | ATE552500T1 (de) |
AU (1) | AU2006231470B2 (de) |
CA (1) | CA2604039C (de) |
DE (1) | DE602006014812D1 (de) |
DK (1) | DK1869459T3 (de) |
ES (1) | ES2345506T3 (de) |
PT (1) | PT1869459E (de) |
WO (1) | WO2006107921A2 (de) |
Families Citing this family (34)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7374896B2 (en) * | 2001-08-28 | 2008-05-20 | Allergan, Inc. | GFP-SNAP25 fluorescence release assay for botulinum neurotoxin protease activity |
US7332567B2 (en) * | 2001-08-28 | 2008-02-19 | Allergan, Inc. | Fret protease assays for clostridial toxins |
US8022172B2 (en) * | 2001-08-28 | 2011-09-20 | Allergan, Inc. | Luminescence resonance energy transfer (LRET) assays for clostridial toxin activity |
US7183066B2 (en) * | 2002-09-27 | 2007-02-27 | Allergan, Inc. | Cell-based fluorescence resonance energy transfer (FRET) assays for clostridial toxins |
US8497081B2 (en) | 2004-02-24 | 2013-07-30 | Allergan, Inc. | Botulinum toxin screening assays |
US7598027B2 (en) * | 2004-02-24 | 2009-10-06 | Allergan, Inc. | Botulinum toxin screening assays |
EP2293064B1 (de) * | 2005-04-05 | 2012-04-04 | Allergan, Inc. | Lipophile, farbstoffbasierte FRET-Assays für die Clostridientoxinaktivität |
DE602006012072D1 (de) * | 2005-10-12 | 2010-03-18 | Allergan Inc | Tests der molekularen oder subzellulären interaktivität unter verwendung von depolarisierung nach resonanzenergietransfer (daret) |
JP2010516688A (ja) | 2007-01-16 | 2010-05-20 | ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア | 抗菌ペプチド |
PL2271670T3 (pl) | 2008-03-14 | 2015-05-29 | Allergan Inc | Testy aktywności serotypu A toksyny botulinowej oparte na immunologii |
KR101604515B1 (ko) * | 2008-03-14 | 2016-03-17 | 알러간, 인코포레이티드 | 면역-기반 보툴리눔 독소 세로타입 a 활성 검정 |
EP2406371B1 (de) | 2009-03-13 | 2018-05-09 | Allergan, Inc. | Für botulinumtoxin-serotyp-a-aktivitätstests auf immunbasis geeignete zellen |
PT3281953T (pt) | 2009-03-13 | 2020-01-15 | Allergan Inc | Ensaios de base imunológica da actividade de endopeptidase redireccionada |
US8129139B2 (en) | 2009-07-13 | 2012-03-06 | Allergan, Inc. | Process for obtaining botulinum neurotoxin |
LT3067696T (lt) * | 2009-10-16 | 2018-09-10 | Biomadison, Inc. | Genetiškai modifikuotos ląstelės, skirtos rezonansiniam energijos perdavimo tyrimui su sinaptobrevino substrato dalimi |
US10246492B2 (en) | 2009-10-16 | 2019-04-02 | Biomadison, Inc. | Botulinum assay with synaptobrevin substrate moiety |
JP2013534415A (ja) * | 2010-06-11 | 2013-09-05 | シナプティック リサーチ,リミテッド ライアビリティ カンパニー | N末端ルール・プロテアーゼ同定方法及びその使用法 |
ES2648899T3 (es) * | 2011-12-09 | 2018-01-08 | Institut Pasteur | Inmunoensayo de cribado múltiplex |
EP2798077A2 (de) | 2011-12-31 | 2014-11-05 | Allergan, Inc. | Hochempfindlicher zellbasierter test für den nachweis der anwesenheit von aktivem botulinum-neurotoxin-serotyp-a |
US8778623B2 (en) * | 2012-09-14 | 2014-07-15 | Wisconsin Alumni Research Foundation | Compositions and methods of using differentiated cells sensitized to botulinum neurotoxin |
US8962340B2 (en) | 2012-12-03 | 2015-02-24 | Src, Inc. | Real-time assay for the detection of botulinum toxin |
DE102013226511B4 (de) | 2013-12-18 | 2016-12-15 | TRUMPF Hüttinger GmbH + Co. KG | Leistungsversorgungssystem und Verfahren zur Erzeugung einer Leistung |
DE102013226537B4 (de) | 2013-12-18 | 2022-12-29 | TRUMPF Hüttinger GmbH + Co. KG | Leistungsversorgungssystem mit mehreren Verstärkerpfaden sowie Verfahren zur Anregung eines Plasmas |
JP6630717B2 (ja) | 2014-07-07 | 2020-01-15 | アラーガン、インコーポレイテッドAllergan,Incorporated | 組織試料における切断snap25の検出方法 |
US9788776B1 (en) | 2014-09-22 | 2017-10-17 | Verily Life Sciences Llc | Protein M-based in vivo diagnostic system and detection method |
US9927442B1 (en) | 2014-10-31 | 2018-03-27 | Verily Life Sciences Llc | Biosensor for in vitro detection system and method of use |
AU2015367329B2 (en) * | 2014-12-19 | 2021-02-18 | Merz Pharma Gmbh & Co. Kgaa | Means and methods for the determination of the biological activity of BoNT/E in cells |
JP7217700B2 (ja) | 2016-09-13 | 2023-02-03 | アラーガン、インコーポレイテッド | 安定化非タンパク質クロストリジウム毒素組成物 |
US11129906B1 (en) | 2016-12-07 | 2021-09-28 | David Gordon Bermudes | Chimeric protein toxins for expression by therapeutic bacteria |
CN112351992A (zh) | 2017-12-20 | 2021-02-09 | 阿勒根公司 | 肉毒杆菌毒素细胞结合结构域多肽及其用于皮肤再生的方法 |
TW202113072A (zh) * | 2019-06-07 | 2021-04-01 | 美商辛那皮克研究有限責任公司 | 基因工程化細胞 |
WO2021028868A1 (en) * | 2019-08-13 | 2021-02-18 | Synaptic Research, Llc | Cells highly sensitive to clostridial neurotoxin |
CN110840914B (zh) * | 2019-11-23 | 2021-07-06 | 博雅干细胞科技有限公司 | 细胞治疗剂用于缓解或改善血管病变的方法 |
CN110882276B (zh) * | 2019-11-23 | 2021-07-06 | 博雅干细胞科技有限公司 | 细胞治疗组合物及治疗血管病变的方法 |
Family Cites Families (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5965699A (en) * | 1996-11-06 | 1999-10-12 | The United States Of America As Represented By The Secretary Of The Army | Assay for the proteolytic activity of serotype a from clostridium botulinum |
US7090976B2 (en) * | 1999-11-10 | 2006-08-15 | Rigel Pharmaceuticals, Inc. | Methods and compositions comprising Renilla GFP |
FR2809733B1 (fr) | 2000-06-02 | 2004-04-30 | Inst Nat Sante Rech Med | Substrat peptidique reconnu par la toxine botulique de type bont/b et son utilisation pour doser et/ou detecter ladite toxine ou des inhibiteurs correspondants |
AU2001294771A1 (en) | 2000-09-25 | 2002-04-02 | U.S. Medical Research Institute Of Infectious Diseases | High-throughput assays for the proteolytic activities of clostridial neurotoxins |
US7374896B2 (en) | 2001-08-28 | 2008-05-20 | Allergan, Inc. | GFP-SNAP25 fluorescence release assay for botulinum neurotoxin protease activity |
US7332567B2 (en) | 2001-08-28 | 2008-02-19 | Allergan, Inc. | Fret protease assays for clostridial toxins |
US7208285B2 (en) | 2001-08-28 | 2007-04-24 | Allergan, Inc. | Fret protease assays for botulinum serotype A/E toxins |
US20060063221A1 (en) * | 2004-09-21 | 2006-03-23 | Williams Dudley J | Lanthanide-based substrates and methods for determining clostridial toxin activity |
WO2004020748A1 (en) | 2002-08-28 | 2004-03-11 | Btb Wallercode Sdn Bhd | Rainwater collection, storage and supply system |
WO2004029567A1 (en) | 2002-09-26 | 2004-04-08 | Rensselaer Polytechnic Institute | Analytical instruments for monitoring photopolymerization |
US7183066B2 (en) | 2002-09-27 | 2007-02-27 | Allergan, Inc. | Cell-based fluorescence resonance energy transfer (FRET) assays for clostridial toxins |
AU2003272800A1 (en) | 2002-10-01 | 2004-04-23 | University Of Maryland | Methods for identifying inhibitors of botulinum neurotoxins |
US20050100983A1 (en) * | 2003-11-06 | 2005-05-12 | Coley Pharmaceutical Gmbh | Cell-free methods for identifying compounds that affect toll-like receptor 9 (TLR9) signaling |
US8137924B2 (en) * | 2003-12-19 | 2012-03-20 | Wisconsin Alumni Research Foundation | Method and compositions for detecting botulinum neurotoxin |
US7875436B2 (en) | 2004-05-05 | 2011-01-25 | Pharmaleads | Peptide substrates recognizable by a botulinum toxin A, BoNT/A and the use thereof |
US7399607B2 (en) | 2004-09-22 | 2008-07-15 | Allergan, Inc. | Fluorescence polarization assays for determining clostridial toxin activity |
EP2293064B1 (de) * | 2005-04-05 | 2012-04-04 | Allergan, Inc. | Lipophile, farbstoffbasierte FRET-Assays für die Clostridientoxinaktivität |
-
2006
- 2006-04-04 EP EP10164461A patent/EP2293064B1/de not_active Not-in-force
- 2006-04-04 ES ES06749210T patent/ES2345506T3/es active Active
- 2006-04-04 WO PCT/US2006/012426 patent/WO2006107921A2/en active Application Filing
- 2006-04-04 DE DE602006014812T patent/DE602006014812D1/de active Active
- 2006-04-04 AT AT10164461T patent/ATE552500T1/de active
- 2006-04-04 CA CA2604039A patent/CA2604039C/en not_active Expired - Fee Related
- 2006-04-04 DK DK06749210.8T patent/DK1869459T3/da active
- 2006-04-04 AT AT06749210T patent/ATE470857T1/de active
- 2006-04-04 US US11/908,438 patent/US8124357B2/en not_active Expired - Fee Related
- 2006-04-04 PT PT06749210T patent/PT1869459E/pt unknown
- 2006-04-04 EP EP06749210A patent/EP1869459B1/de not_active Not-in-force
- 2006-04-04 AU AU2006231470A patent/AU2006231470B2/en not_active Ceased
-
2012
- 2012-02-27 US US13/406,224 patent/US8535941B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
EP2293064A1 (de) | 2011-03-09 |
EP1869459A2 (de) | 2007-12-26 |
ATE470857T1 (de) | 2010-06-15 |
ES2345506T3 (es) | 2010-09-24 |
PT1869459E (pt) | 2010-08-10 |
CA2604039C (en) | 2014-09-16 |
AU2006231470B2 (en) | 2011-12-01 |
CA2604039A1 (en) | 2006-10-12 |
DE602006014812D1 (de) | 2010-07-22 |
WO2006107921A3 (en) | 2007-01-18 |
US20080160561A1 (en) | 2008-07-03 |
US8124357B2 (en) | 2012-02-28 |
EP2293064B1 (de) | 2012-04-04 |
WO2006107921A2 (en) | 2006-10-12 |
US8535941B2 (en) | 2013-09-17 |
EP1869459B1 (de) | 2010-06-09 |
AU2006231470A1 (en) | 2006-10-12 |
US20120231538A1 (en) | 2012-09-13 |
DK1869459T3 (da) | 2010-09-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE470857T1 (de) | Lipophile, farbstoffbasierte fret-assays für die clostridientoxinaktivität | |
NO20051049D0 (no) | Celle-baserte fluorescens-resonans energi overforings (FRET)-analyser for Clostridietoksiner | |
DK1920248T3 (da) | Clostridialt-toksin-aktivitetsassays | |
ATE528648T1 (de) | Verfahren zum nachweis antikörper-herstellender zellen | |
WO2004041061A3 (en) | Substrates, devices, and methods for cellular assays | |
DE602006018477D1 (de) | Dna und antikörpern sowie verwendungen davon | |
ATE527383T1 (de) | Multiplex-nukleinsäurenachweis | |
ATE532830T1 (de) | Langwellige thiolgruppenreaktive fluorophore | |
WO2007103859A3 (en) | Methods, products, and kits for identifying an analyte in a sample | |
WO2006071247A3 (en) | Diagnostic assays including multiplexed lateral flow immunoassays with quantum dots | |
WO2005005977A3 (en) | Fluorescent phospholipase assays and compositions | |
AU4701200A (en) | A method of detecting an analyte using semiconductor nanocrystals | |
WO2006121799A3 (en) | Liquid crystal based analyte detection | |
WO2007008276A3 (en) | Turnover probes and use thereof for nucleic acid detection | |
WO2005047863A3 (en) | Substrates, devices, and methods for cellular assays | |
TW200720441A (en) | New labelling strategies for the sensitive detection of analytes | |
WO2008066584A3 (en) | Rapid analyte measurement assay | |
WO2011142781A3 (en) | Pore-limit electrophoresis (ple) microchannel assays | |
WO2006044747A3 (en) | P27 ubiquitination assay and methods of use | |
ATE467128T1 (de) | Kolloidale metallkonjugate | |
WO2005094441A3 (en) | Split enzyme linked immunosorbent and nucleic acid assays | |
ATE533053T1 (de) | Nicht-elispot-test | |
WO2009017234A1 (ja) | γ-セクレターゼの新規基質c-Retを利用したスクリーニング方法 | |
DE60331686D1 (de) | Mikroarray-vorrichtungen mit steuerbarem reaktionsvolumen | |
ATE529749T1 (de) | Chromatographische teststreifen für ein oder mehrere analyte |